Lipopolysaccharide Receptors
"Lipopolysaccharide Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.
| Descriptor ID |
D018950
|
| MeSH Number(s) |
D12.776.395.550.448.100 D12.776.543.484.500.100 D12.776.543.550.418.100 D12.776.543.750.705.045 D23.050.301.264.900.045 D23.101.100.900.045
|
| Concept/Terms |
Lipopolysaccharide Receptors- Lipopolysaccharide Receptors
- Lipoglycan Receptor
- Receptor, Lipoglycan
- Receptors, Lipopolysaccharide
- CD14 Antigens
- Antigens, CD14
- LPS Receptor
- Receptor, LPS
- CD14 Monocyte Differentiation Antigen
- CD14 Antigen
|
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharide Receptors".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- GPI-Linked Proteins [D12.776.395.550.448]
- Lipopolysaccharide Receptors [D12.776.395.550.448.100]
- Membrane Proteins [D12.776.543]
- Lipid-Linked Proteins [D12.776.543.484]
- GPI-Linked Proteins [D12.776.543.484.500]
- Lipopolysaccharide Receptors [D12.776.543.484.500.100]
- Membrane Glycoproteins [D12.776.543.550]
- GPI-Linked Proteins [D12.776.543.550.418]
- Lipopolysaccharide Receptors [D12.776.543.550.418.100]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Lipopolysaccharide Receptors [D12.776.543.750.705.045]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
- Lipopolysaccharide Receptors [D23.050.301.264.900.045]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, Myelomonocytic [D23.101.100.900]
- Lipopolysaccharide Receptors [D23.101.100.900.045]
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharide Receptors".
This graph shows the total number of publications written about "Lipopolysaccharide Receptors" by people in this website by year, and whether "Lipopolysaccharide Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 4 | 6 |
| 2008 | 0 | 2 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 2 | 4 |
| 2013 | 0 | 3 | 3 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 2 | 3 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipopolysaccharide Receptors" by people in Profiles.
-
Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes. PLoS One. 2019; 14(9):e0222912.
-
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol. 2019 Sep; 46(9):627-636.
-
Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):417-426.
-
Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection. Clin Infect Dis. 2017 Oct 30; 65(10):1638-1643.
-
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):500-508.
-
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017 07 13; 130(2):167-175.
-
The Polarization of M2b Monocytes in Cultures of Burn Patient Peripheral CD14+ Cells Treated with a Selected Human CCL1 Antisense Oligodeoxynucleotide. Nucleic Acid Ther. 2016 10; 26(5):269-276.
-
Factors that promote macrophage homing to adipose tissue in metabolic syndrome. J Diabetes Complications. 2016 Nov - Dec; 30(8):1434-1436.
-
Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People. AIDS Res Hum Retroviruses. 2016 12; 32(12):1205-1209.
-
Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? J Acquir Immune Defic Syndr. 2016 06 01; 72(2):206-213.